Research Library
Peptide Research, Explained
Evergreen guides on purity, documentation, handling, and the compounds themselves — written as research and procurement education. For laboratory research use only.
Selank Mechanism of Action
How the tuftsin-derived heptapeptide Selank is proposed to act in research models.
Read article →
Semax Mechanism of Action
How the ACTH-derived heptapeptide Semax is proposed to act in neuro-research models.
Read article →
Melanotan-II Mechanism of Action
How the cyclic melanocortin-receptor agonist is proposed to act in research models.
Read article →
KPV Mechanism of Action
How the C-terminal tripeptide KPV is proposed to act in regulatory-signaling research.
Read article →
TB-500 (Thymosin Beta-4) Mechanism of Action
How the actin-binding thymosin beta-4 fragment is proposed to act in research models.
Read article →
Hexarelin Mechanism of Action
How the potent GHRP-family secretagogue engages the ghrelin receptor in research models.
Read article →
Tesamorelin Mechanism of Action
How the stabilized GHRH analog engages the GHRH receptor in research models.
Read article →
CJC-1295 DAC Mechanism of Action
How the albumin-binding long-acting GHRH analog is proposed to act in research models.
Read article →
CJC-1295 (No DAC) Mechanism of Action
How the short-acting GHRH analog is proposed to act at the GHRH receptor in research models.
Read article →
MOTS-c Mechanism of Action
How the mitochondrial-derived peptide is proposed to act in research models.
Read article →
Cagrilintide Mechanism of Action
How the long-acting amylin analog engages amylin-receptor complexes in research models.
Read article →
IGF-1 LR3 Mechanism of Action
How the Long R3 IGF-1 analog engages the IGF-1 receptor in research models.
Read article →
AOD-9604 Mechanism of Action
How the growth-hormone C-terminal fragment is proposed to act in research models.
Read article →
KLOW Stack Mechanism of Action
How the component motifs of the KLOW stack are proposed to act in research models.
Read article →
GHK-KPV Mechanism of Action
How the GHK and KPV motifs are proposed to act in research models.
Read article →
PT-141 Mechanism of Action
How bremelanotide engages melanocortin receptors in research models.
Read article →
Ipamorelin Mechanism of Action
How the selective secretagogue engages the ghrelin/GHS receptor in research models.
Read article →
Sermorelin Mechanism of Action
How the GHRH(1-29) analog engages the GHRH receptor in research models.
Read article →
NAD+ Mechanism of Action in Research
How nicotinamide adenine dinucleotide functions as a redox cofactor and signaling substrate.
Read article →
CJC-1295 & Ipamorelin Mechanism of Action
How the GHRH-analog + secretagogue pairing is studied in growth-factor signaling.
Read article →
GHK-Cu Mechanism of Action in Research
How the copper-binding tripeptide GHK-Cu is studied at the signaling and gene-expression level.
Read article →
BPC-157 Mechanism of Action in Research Models
The tissue-response and signaling pathways BPC-157 is studied in.
Read article →
Retatrutide Mechanism of Action (Triple Agonism)
How retatrutide's triple GIP/GLP-1/glucagon receptor activity is studied.
Read article →
Semaglutide Mechanism of Action in Research
How semaglutide's long-acting GLP-1 receptor agonism is studied at the signaling level.
Read article →
Tirzepatide Mechanism of Action in Research Models
How tirzepatide's dual GIP/GLP-1 receptor activity is studied at the receptor and signaling level.
Read article →